160 related articles for article (PubMed ID: 8780159)
21. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes.
Masten SA; Shiverick KT
Biochem Biophys Res Commun; 1995 Jul; 212(1):27-34. PubMed ID: 7541987
[TBL] [Abstract][Full Text] [Related]
22. [Detection of IgH gene rearrangement in Reed-Sternberg cells microdissected from classical Hodgkin's lymphoma].
Zhou X; Zhao T; Shen XM; Yu J; Zhu MG
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):286-9. PubMed ID: 15041542
[TBL] [Abstract][Full Text] [Related]
23. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation.
Singh M; Birshtein BK
Mol Cell Biol; 1993 Jun; 13(6):3611-22. PubMed ID: 8497273
[TBL] [Abstract][Full Text] [Related]
24. A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3' of the Ig H chain gene cluster.
Liao F; Giannini SL; Birshtein BK
J Immunol; 1992 May; 148(9):2909-17. PubMed ID: 1349323
[TBL] [Abstract][Full Text] [Related]
25. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
26. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box.
Riva A; Wilson GL; Kehrl JH
J Immunol; 1997 Aug; 159(3):1284-92. PubMed ID: 9233624
[TBL] [Abstract][Full Text] [Related]
27. Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner.
Waterman ML; Jones KA
New Biol; 1990 Jul; 2(7):621-36. PubMed ID: 2083253
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells.
Hsu SM; Hsu PL
Am J Pathol; 1990 Sep; 137(3):563-74. PubMed ID: 1698024
[TBL] [Abstract][Full Text] [Related]
29. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
[TBL] [Abstract][Full Text] [Related]
30. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
[TBL] [Abstract][Full Text] [Related]
31. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
Kozmik Z; Wang S; Dörfler P; Adams B; Busslinger M
Mol Cell Biol; 1992 Jun; 12(6):2662-72. PubMed ID: 1375324
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells.
Hummel M; Ziemann K; Lammert H; Pileri S; Sabattini E; Stein H
N Engl J Med; 1995 Oct; 333(14):901-6. PubMed ID: 7545266
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
35. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
[TBL] [Abstract][Full Text] [Related]
36. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
[TBL] [Abstract][Full Text] [Related]
37. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.
Zwollo P; Desiderio S
J Biol Chem; 1994 May; 269(21):15310-7. PubMed ID: 8195169
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?
Hsu SM; Hsu PL
Am J Pathol; 1989 Jan; 134(1):203-12. PubMed ID: 2492402
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29 mu B cell line.
Qiu G; Stavnezer J
J Immunol; 1998 Sep; 161(6):2906-18. PubMed ID: 9743352
[TBL] [Abstract][Full Text] [Related]
40. A human early B-cell factor-like protein participates in the regulation of the human CD19 promoter.
Gisler R; Akerblad P; Sigvardsson M
Mol Immunol; 1999; 36(15-16):1067-77. PubMed ID: 10698309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
